Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

966
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
966
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

563
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
563
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

577
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
577

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Direct Thrombectomy vs. Combined Treatment With Intravenous Thrombolysis in the Extended Time Window: A Target Trial Emulation.

European journal of neurology·2026
Same author

Recurrence Patterns and Overtreatment in Pure DCIS: A Retrospective Clinical and Radiological Follow-Up Study.

Journal of personalized medicine·2026
Same author

CT Quantification of Intraventricular Hemorrhage Volume in Poor-Grade Aneurysmal Subarachnoid Hemorrhage: Impact on Mortality and Long-Term Disability.

Neurocritical care·2026
Same author

ALIGNED Network for rare cerebrovascular diseases: methodology and preliminary results.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Cortical correlates of apathy in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy with two different pathogenic mutations in the NOTCH3 gene.

Neuropsychology·2026
Same author

MRI staging of haemodynamic congestion and clinical outcomes.

European radiology·2026
Same journal

Orbital Imaging.

Radiologic clinics of North America·2026
Same journal

Imaging, Management, and Treatment of Orbital Trauma.

Radiologic clinics of North America·2026
Same journal

Imaging Findings after Multidisciplinary Treatment for Orbital and Ocular Adnexal Cancers.

Radiologic clinics of North America·2026
Same journal

Orbital Tumors: What the Radiologist Needs to Know from the Orbital Surgeon's Perspective.

Radiologic clinics of North America·2026
Same journal

Multidisciplinary Management of Tumors of the Orbit.

Radiologic clinics of North America·2026
Same journal

Skull Base, Bone, Pituitary-Regions around Orbit that Affect Vision.

Radiologic clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Feb 8, 2026

Olfactory Assays for Mouse Models of Neurodegenerative Disease
07:27

Olfactory Assays for Mouse Models of Neurodegenerative Disease

Published on: August 25, 2014

22.7K

Neurodegenerative diseases.

Massimo Gallucci1, Nicola Limbucci, Alessia Catalucci

  • 1Department of Neuroradiology, S. Salvatore Hospital, University of L'Aquila, 67100 Loc. Coppito, L'Aquila, Italy. massimo.gallucci@cc.univaq.it

Radiologic Clinics of North America
|October 17, 2008
PubMed
Summary
This summary is machine-generated.

This article details brain imaging changes in normal aging and various diseases, including dementias and extrapyramidal disorders. It highlights key imaging findings for accurate diagnosis and understanding of neurological conditions.

More Related Videos

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

18.1K
Interview: Protein Folding and Studies of Neurodegenerative Diseases
19:50

Interview: Protein Folding and Studies of Neurodegenerative Diseases

Published on: July 16, 2008

13.2K

Related Experiment Videos

Last Updated: Feb 8, 2026

Olfactory Assays for Mouse Models of Neurodegenerative Disease
07:27

Olfactory Assays for Mouse Models of Neurodegenerative Disease

Published on: August 25, 2014

22.7K
High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

18.1K
Interview: Protein Folding and Studies of Neurodegenerative Diseases
19:50

Interview: Protein Folding and Studies of Neurodegenerative Diseases

Published on: July 16, 2008

13.2K

Area of Science:

  • Neurology
  • Radiology
  • Gerontology

Background:

  • Normal brain aging involves specific neuroimaging changes.
  • Pathologic conditions significantly alter brain structure and function detectable by imaging.
  • Differentiating normal aging from disease is crucial for diagnosis.

Purpose of the Study:

  • To review imaging findings in the normally aging brain.
  • To detail imaging characteristics of various pathologic brain conditions.
  • To cover primary degenerative dementias, extrapyramidal diseases, and vascular dementias.

Main Methods:

  • Review of neuroimaging literature.
  • Discussion of findings from various imaging modalities (e.g., MRI, CT).
  • Comparative analysis of imaging in aging versus disease states.

Main Results:

  • Normal aging shows predictable patterns of brain volume and white matter changes.
  • Primary degenerative dementias exhibit distinct patterns of atrophy and functional changes.
  • Extrapyramidal diseases and vascular dementias present unique imaging signatures.

Conclusions:

  • Neuroimaging is essential for characterizing brain aging and diagnosing neurological disorders.
  • Understanding imaging changes aids in differentiating normal aging from pathologic conditions.
  • This review provides a framework for interpreting brain imaging in clinical practice.